Phase II randomized trial comparing metronomic anthracycline-containing chemotherapy versus standard schedule in untreated HER2 negative advanced breast cancer: activity and quality of life results of the GOIM 21003 trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase II randomized trial comparing metronomic anthracycline-containing chemotherapy versus standard schedule in untreated HER2 negative advanced breast cancer: activity and quality of life results of the GOIM 21003 trial

Published:2024-06 Issue: Volume:75 Page:103725
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Orlando Laura,Maiello Evaristo,Orditura Michele,Diana Anna,Antoniol Giuliano,Morritti Maria Grazia,Aieta Michele,Ciccarese Mariangela,Pisconti Salvatore,Bordonaro Roberto,Russo Antonio,Febbraro Antonio,Schiavone Paola,Quaranta Annamaria,Caliolo Chiara,Loparco Dario,Cinefra Margherita,Colucci Giuseppe,Cinieri Saverio

Publisher

Elsevier BV

Reference17 articles.

1. Global cancer incidence and mortality rates and trends: an update;Torre;Cancer Epidemiol Biomarkers Prev,2016

2. Treatment of breast cancer;Hortobagyi;N Engl J Med,1998

3. Single agent versus combination chemotherapy for metastatic breast cancer;Carrick;Cochrane Database Syst Rev,2009

4. Phase III trial of doxorubicin, paclitaxel and the combination of doxorubicin and paclitaxel as front line chemotherapy in metastatic breast cancer: an intergroup trial (E1193);Sledge;J Clin Oncol,2003

5. First line chemotherapy of metastatic breast cancer;Pronzato;Ann Oncol,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP